The genetics of acute myeloid leukaemia

  • Research type

    Research Study

  • Full title

    Paired exome sequencing of familial acute myeloid leukaemia

  • IRAS ID

    125623

  • Contact name

    Dominic J Culligan

  • Contact email

    dominic.culligan@nhs.net

  • Sponsor organisation

    University of Aberdeen & NHS Grampian

  • Research summary

    The study team had identified two related individuals who were diagnosed and treated for acute myeloid leukaemia, both of whom carried an identical pattern of chromosomal abnormalities in their leukaemia cells. This combination occurred much more often than would be expected by chance and suggested it might be influenced by a specific genetic abnormality. Individuals with leukaemia who carried this chromosomal pattern typically had a dreadful response to intensive chemotherapy, with only a small proportion achieving disease remission.

    The study team believed that further study of these two related individuals offered a unique opportunity to better understand the origins of leukaemia. The study team proposed to utilise next generation genetic sequencing technology to identify the genetic factors responsible in the two related individuals. Better understanding of this subtype of Acute Myeloid Leukaemia (AML) might lead to new therapeutic avenues, which would greatly benefit a group of patients who currently exhibited a dreadful outcome with conventional treatment.

  • REC name

    North of Scotland Research Ethics Committee 2

  • REC reference

    14/NS/0004

  • Date of REC Opinion

    13 Jan 2014

  • REC opinion

    Favourable Opinion